Cite
HARVARD Citation
Distler, E. et al. (n.d.). Patient‐individualized CD8+ cytolytic T‐cell therapy effectively combats minimal residual leukemia in immunodeficient mice. International journal of cancer. 138 (5), pp. 1256-1268. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Distler, E. et al. (n.d.). Patient‐individualized CD8+ cytolytic T‐cell therapy effectively combats minimal residual leukemia in immunodeficient mice. International journal of cancer. 138 (5), pp. 1256-1268. [Online].